News >

Emerging Findings Offer Hope With Less Common Genomic Drivers of Lung Cancer

Angelica Welch
Published: Monday, Apr 23, 2018

Dr Alexander Drilon
Alexander Drilon, MD
Non–small cell lung cancer (NSCLC) is highly enriched for genomic drivers, and many are clinically actionable. Targeted therapies are currently available in the clinic to treat patients who harbor these mutations, with several that are FDA approved and more that are incorporated into the NCCN guidelines. 
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication